Innovating Works

Firalis

Desconocido
ONCOSCREEN: A European shield against colorectal cancer based on novel, more precise and affordable risk-based s... FIRALIS participó en un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 With Colorectal Cancer (CRC) being accountable for 12.4% of all deaths due to cancer, and with only 14% of EU citizens participating in scre...
2022-11-28 - 2026-12-31 | Financiado
TALENTS: Training AlliancE for Novel Microbiome-Modulating TherapieS FIRALIS participó en un HORIZON EUROPE: HORIZON-MSCA-2021-COFUND-01 TALENTS aims to build up an international programme for interdisciplinary and transsectorial training of 15 doctoral candidates (DCs) as nee...
2022-09-02 - 2027-12-31 | Financiado
COVIRNA: A diagnostic test to improve surveillance and care of COVID 19 patients FIRALIS participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 Coronavirus disease 2019 (COVID-19) caused by infection with SARS coronavirus 2 (SARS-CoV-2) has reached pandemic proportions with more than...
2020-10-13 - 2023-04-30 | Financiado
HELICAL: HEalth data LInkage for ClinicAL benefit FIRALIS participó en un H2020: H2020-MSCA-ITN-2018 European researchers have made leading contributions to the large genomic, transcriptomic and clinical datasets from patients with chronic d...
2018-08-31 - 2023-06-30 | Financiado
ADDIA: Validation of a fast and simple peripheral blood diagnostic biomarker kit for Alzheimer s disease FIRALIS participó en un H2020: H2020-SMEInst-2014-2015 The French SME Amoneta Diagnostics has previously developed a diagnostic kit for Alzheimer’s disease (AD) based on two blood biomarkers that...
2015-07-10 - 2019-07-31 | Financiado
RABIOPRED: RABIOPRED Clinical validation of BIOmarker assay to PREDict treatment response in Rheumatoid Arthr... FIRALIS participó en un H2020: H2020-SMEInst-2014-2015 The aim of the RABIOPRED project is to take the final steps to bring an innovative set of biomarkers that is able to predict response to tre...
2015-06-02 - 2018-12-31 | Financiado
BTCURE: BeTheCuRE FIRALIS participó en un FP6: BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal model...
2011-04-01 - 2017-03-31 | Financiado
SAFE-T: SAFER AND FASTER EVIDENCE-BASED TRANSLATION FIRALIS participó en un FP6: The public-private consortium composed of complementary SMEs, academic and clinical centers of excellence and EMEA as partner proposes SAFE-...
2009-06-15 - 2015-06-14 | Financiado
BRAINVECTORS: From Brain Gene Transfer Towards Gene Therapy Pharmacological Assessment of AAV CAV and LVV FIRALIS participó en un FP7: "BRAINVECTORS aims devising new gene therapy(GT)-based treatments for Parkinson’s and other neurodegenerative diseases, in substitution of c...
Financiado
BTCURE: BeTheCuRE FIRALIS participó en un FP7: BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal model...
Financiado
MITOCARE: Treatment of reperfusion injury using a mitochondrial targeted approach towards a better understand... Current interventional treatment of acute myocardial infarction (AMI) focused on re-establishing cardiac reperfusion has significantly impro...
Financiado
FIBRO-TARGETS: Targeting cardiac fibrosis for heart failure treatment FIRALIS participó en un FP7: The Fibro-Targets project is a multi-disciplinary 4 years program involving 10 partners ambitioning the identification, characterisation and...
Financiado
SAFE-T: SAFER AND FASTER EVIDENCE BASED TRANSLATION FIRALIS participó en un FP7: The public-private consortium composed of complementary SMEs, academic and clinical centers of excellence and EMEA as partner proposes SAFE-...
Financiado
IMAGINT: HER Imaging and Molecular Interaction Mapping in Breast Cancer FIRALIS participó en un FP7: The aim is to develop tools for imaging and characterising protein/protein and protein/RNA interactions in cancer using Designed Ankyrin Rep...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.